-
MJBizCon Association Day in Las Vegas (November 28, 2023): ECA to Attend as Partner and Exhibitor
The European Cannabis Association is pleased to announce its attendance as a partner and exhibitor of the MJBizCon Association Day in Las Vegas. November 28, 2023Las Vegas Convention Center2:00 – 5:00 pm “Associations Day at MJBizCon 2023 will bring together over 40 non-profits and associations driving the industry forward. It’s your chance to meet and…
-
Global Cannabis Award for Influential Advocacy in European Cannabis Industry
The award recognizes the ECA for its effective advocacy of the European cannabis industry before influential European authorities. The award underlines ECA’s commitment to actively shaping and influencing policy discussions at the European level.
-
Cannabis Europa: Igniting Growth and Collaboration in the Cannabis Industry
The Cannabis Europa London 2023 trade show proved to be a successful event that brought together numerous stakeholders from the cannabis industry.
-
Cannabis Europa: ECA to Attend as Exhibitor and Media Partner of Prohibition Partners
On 12 April 2023, Federal ministers Karl Lauterbach (Health) and Cem Özdemir (Food and Agriculture) presented a new key issues paper of the Federal Government (in German) on the legalization of cannabis for consumption purposes in Germany.
-
New key issues paper on cannabis legalization in Germany
On 12 April 2023, Federal ministers Karl Lauterbach (Health) and Cem Özdemir (Food and Agriculture) presented a new key issues paper of the Federal Government (in German) on the legalization of cannabis for consumption purposes in Germany.
-
New details on the implementation of cannabis legalization
On October 25, the German Federal Ministry of Health, with Karl Lauterbach as Minister of Health, published a key points paper on the introduction of controlled dispensing of cannabis to adults for recreational purposes. The Federal Cabinet approved Health Minister Karl Lauterbach’s planned key points for the legalization of cannabis on October 26, 2022.
-
CDMO Excellence in Phytocannabinoid Products
CB21 Pharma Ltd announces that it entered a global strategic collaboration to combine
its leading expertise and clinical research program in phytocannabinoids with world-class
pharmaceutical strategic consulting and business development services of NorthStar Corporate
Finance Ltd and Krüger Beteiligungs GmbH, forming a new company called CB21 R&D. -
Dentons erstellt für DEMECAN rechtliches Gutachten zur Legalisierung von Cannabis als Genussmittel in Deutschland
Die globale Wirtschaftskanzlei Dentons hat für die DEMECAN GmbH ein rechtliches Gutachten zur Möglichkeit der Legalisierung von Cannabis zu Genussmittelzwecken in Deutschland erstellt.
-
The Fate of the German Medicinal Cannabis Industry Post-Legalization
Compilation of terms and definitions for Cannabis-derived medicinal products by EMA
-
Compilation of terms and definitions for Cannabis-derived medicinal products
Compilation of terms and definitions for Cannabis-derived medicinal products by EMA